BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2007
View Archived Issues
Six-plasmid HIV-1 DNA vaccine candidate advances to phase II
Read More
Bavarian Nordic reports on U.S. developments
Read More
SBIR grant supports OligoMerix's work in Alzheimer's disease
Read More
Recent Boehringer Ingelheim patent reports novel analgesic agents for migraine
Read More
Sphingozumab effective in animal models of laser-induced CNV
Read More
SQ-109 for TB completes phase Ia trial
Read More
CyDex licenses Captisol enabling technology to Sunesis for Aurora kinase inhibitor
Read More
Rare Disease Therapeutics to market Cystadane in U.S. and Canada
Read More
Peptech and Evogenix to merge
Read More
Viragen to end collaboration with Memorial Sloan-Kettering on VG-101
Read More
Ganaxolone studied for adult partial onset seizures in new phase IIb trial
Read More
Affitech and Roche sign antibody research and licensing agreement
Read More
Brazilian Government issues compulsory license on Stocrin
Read More
KAI-1455 begins phase I trial for prevention of ischemic injury
Read More
Recent patents describe new treatment options for diabetes
Read More
Novel therapeutic agents for cardiovascular disorders reported in recent patent literature
Read More
Ista withdraws European application for Vitragan
Read More
Enrollment open in phase I study of new obesity candidate trodusquemine
Read More
Aastrom cleared for phase III study of bone repair cell product in osteonecrosis
Read More
The mTOR inhibitor QLT-0447 potently suppresses CNV in vivo
Read More
Topically applied TG-101095 shows promise in a murine laser-induced CNV model
Read More
Gentamicin-induced stop codon readthrough shows benefit in a retinitis pigmentosa rat model
Read More
Q1 progress at BioMarin
Read More
Enjuvia receives two new FDA approvals
Read More
Taxus Express2 paclitaxel-eluting coronary stent system launched in Japan
Read More
E.U. approval for pandemic influenza vaccine Focetria
Read More
Pergoveris recommended for E.U. approval
Read More
Circadian recommended for E.U. approval in primary insomnia
Read More